Frederick, MD, United States of America

Teresa Kosakowska-Cholody


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresa Kosakowska-Cholody: Innovator in Anti-Tumor Compounds

Introduction

Teresa Kosakowska-Cholody is a notable inventor based in Frederick, MD (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-tumor activity. Her work is characterized by a commitment to advancing cancer treatment through innovative chemical solutions.

Latest Patents

Teresa holds a patent for her invention titled "1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity." This invention provides imidazoacridone compounds of general formula (1) that exhibit cytotoxic and anti-tumor properties. The patent also outlines methods for preparing these compounds and their application in treating cancer and other diseases associated with excessive cell proliferation. The compounds are anticipated to serve as valuable research tools in the medical field.

Career Highlights

Teresa is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has been instrumental in the development of therapeutic agents aimed at combating cancer, showcasing her dedication to improving health outcomes through scientific innovation.

Collaborations

Some of her notable coworkers include Wieslaw Marek Cholody and Christopher J Michejda. Their collaborative efforts have contributed to the advancement of research in the field of anti-tumor compounds.

Conclusion

Teresa Kosakowska-Cholody's innovative work in developing anti-tumor compounds highlights her significant role in the fight against cancer. Her contributions not only advance scientific knowledge but also hold promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…